Skip to content
Home/Companies/Healthcare/KabaFusion

KabaFusion

Healthcare·United States·Exited 2026·Held 4yr
Entry
2022
Hold
4yr
Exit
2026

Who owns KabaFusion?

KabaFusion is an American Healthcare company, now owned by Nautic Partners, which acquired it in 2026 from Novo Holdings.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Investor
Novo Holdings
Novo Holdings Principal Investments · 1999 · Buyout

Key facts

HQUnited States
SectorHealthcare
StatusAcquired
Exit Type
Secondary
Buyer
Nautic Partners
Exit Year
2026

More from Novo Holdings Principal Investments

Other portfolio companies in the same fund.

Tempus AI
Active
HealthTechUS· 2026
Benchmark Genetics
Active
AgTechUK· 2025
KalVista Pharmaceuticals
Active
PharmaUS· 2025
Schott Poonawalla
Active
IndustrialsIndia· 2025
Catalent
Active
PharmaUS· 2024
Inozyme Pharma
Exited 2025
BiotechUS· 2023
to BioMarin Pharmaceutical

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns KabaFusion?

KabaFusion is now owned by Nautic Partners, which acquired it in 2026 from Novo Holdings.

When did Nautic Partners acquire KabaFusion?

Nautic Partners acquired KabaFusion in 2026, buying from Novo Holdings.

Who did KabaFusion sell to?

Novo Holdings sold KabaFusion to Nautic Partners in 2026 (Secondary).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue